Inspirna Appoints Benhadji As CMO, Wasserman Retires
21 May 2024 //
BUSINESSWIRE
Inspirna Partners with Merck to Accelerate Global Development of Ompenaclid
04 Jan 2024 //
BUSINESSWIRE
Inspirna to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04 Jan 2024 //
BUSINESSWIRE
Inspirna Announces Clinical Data from Phase 1b/2 Study of Ompenaclid
23 Oct 2023 //
BUSINESSWIRE
Inspirna to Present Clinical Data from Phase 1b/2 Study of Ompenaclid
16 Oct 2023 //
BUSINESSWIRE
Inspirna to Present at the Jefferies Healthcare Conference
01 Jun 2023 //
BUSINESSWIRE
Inspirna Announces Interim Data from Phase 1b/2 Study of Abequolixron
05 Jan 2023 //
BUSINESSWIRE
Inspirna to Present at the Evercore ISI Annual HealthCONx Conference
17 Nov 2022 //
BUSINESSWIRE
Inspirna Raises $50 Million in Series D Financing
11 Jul 2022 //
BUSINESSWIRE
Inspirna to Present PIb RGX-202-01 Trial Data at the 2022 ESMO
28 Jun 2022 //
BUSINESSWIRE
Inspirna to Present Phase 1b RGX-202-01 Clinical Trial Data at the 2022 ASCO
26 May 2022 //
BUSINESSWIRE